Benzekri, Noelle A.
Sambou, Jacques F.
Ndong, Sanou
Diallo, Mouhamadou Baïla
Tamba, Ibrahima Tito
Faye, Dominique
Sall, Ibrahima
Diatta, Jean Philippe
Faye, Khadim
Cisse, Ousseynou
Sall, Fatima
Guèye, Ndèye Fatou Ngom
Ndour, Cheikh T.
Sow, Papa Salif
Malomar, Jean Jacques
Hawes, Stephen E.
Seydi, Moussa
Gottlieb, Geoffrey S.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (K23 AI120761)
Article History
Received: 16 October 2020
Accepted: 15 February 2021
First Online: 6 March 2021
Ethics approval and consent to participate
: Study procedures were approved by the University of Washington Institutional Review Board (46735-EJ) and the Senegal Comité National d’Ethique pour la Recherche en Santé (SEN16/64). Written informed consent was obtained for participation in this study. For participants < 18 years of age, consent to participate was obtained from their legal guardian.
: Not applicable.
: The authors declare that they have no competing interests related to this work. N.A.B receives research support from the US National Institutes of Health. G.S.G has received research grants and research support from the US National Institutes of Health, University of Washington, Bill and Melinda Gates Foundation, Gilead Sciences, Alere Technologies, Merck & Co., Inc., Janssen Pharmaceutica, Cerus Corporation, ViiV Healthcare, Bristol-Myers Squibb, Thera technologies/TAI Med Biologics and Abbott Molecular Diagnostics. P.S.S is currently employed at Gilead Sciences. S.E.H has received research grants and support from the US National Institutes of Health, University of Washington, and Bill and Melinda Gates Foundation. All other authors have nothing to declare.